A B S T R A C T Rheumatoid synovial collagenase obtained from culture medium can be separated by Sephadex gel filtration into two peaks of enzyme activity. These have been designated as fast-moving and slowmoving rheumatoid synovial collagenases on the basis of their electrophoretic mobility on polyacrylamide gels. The slow-moving rheumatoid synovial collagenase has been highly purified by affinity chromatography on collagen conjugated to Sepharose and used to prepare a monospecific anti-synovial collagenase antiserum.
INTRODUCTION
A possible mechanism for the destruction of cartilage seen in rheumatoid arthritis was suggested by Evanson, Jeffrey, and Krane (1, 2) with the demonstration that rheumatoid synovium in tissue culture synthesizes and releases into the medium a collagenase capable of speReceived for publication 26 March 1971 and in revised form 24 May 1971. cifically degrading native collagen at neutral pH and 370C. Although the enzyme could be found in culture medium of synovial explants from certain other inflammatory diseases (3) , no collagenase was elaborated by normal synovial tissue.
Further evidence that collagenase is involved in the pathogenesis of rheumatoid arthritis came with the detection of collagenase activity in the synovial fluid from some patients with rheumatoid arthritis (4) and the demonstration that rheumatoid synovium is capable of degrading the collagen of whole cartilage (5) . In addition, collagenase activity in rheumatoid arthritis is related to the degree of both local and systemic disease activity (3, 6) . These findings indicate that collagenase derived from synovial tissue can produce the destruction of cartilage seen in rheumatoid arthritis.
The preparation of an antiserum against a purified human skin collagenase has permitted certain relevant observations to be made concerning synovial collagenase (7) . The major finding is that immunologic cross-reactivity exists between human skin and rheumatoid synovial collagenases (7, 8) . In spite of this cross-reactivity, minor variations in antigenic structure, indicative of organ specificity between these human collagenases, could not be investigated until an antiserum prepared against a purified synovial enzyme was available.
Utilizing antiserum to human skin collagenase (9) it has also been shown that collagenase is present in human skin extracts that have no detectable enzymatic activity. Collagenase activity can be recovered from skin extracts by separation of the enzyme from the serum antiproteases, al-antitrypsin, and a2-macroglobulin, which are known to inhibit collagenase (10) . It was also demonstrated that the characteristic delay of 24-48 hr in the appearance of human skin collagenase in the culture medium was related to the inhibition of collagenase activity by serum alpha globulins present in the medium shortly after the tissue explants were initially placed in culture.
A similar delay in the appearance of synovial collagenase into culture medium has also been observed (2) . In addition, a nondialyzable inhibitor of the enzyme was found to be present in the culture medium of synovial explants only during the first 2 days of culture (11) . This inhibitor has not been characterized further and its possible relationship to serum antiproteases is unknown.
In view of the potential significance of synovial collagenase in the pathogenesis of rheumatoid arthritis, a number of important questions arise. (a) Can synovial collagenase be detected in rheumatoid synovium in vivo? (b) Is the lag in the appearance of active synovial collagenase into the medium of cultures of synovial explants related to its inhibition by serum antiproteases? (c) Does immunologic organ specificity exist between human skin and synovial collagenases?
Using a monospecific antiserum, prepared against synovial collagenase purified from the culture medium of rheumatoid synovial explants, we have been able to demonstrate the presence of the synovial enzyme both in vivo and in vitro under circumstances in which serum antiproteases may make its detection impossible. In addition, it has been possible to establish more precisely the relationship of human synovial collagenase to human skin collagenase.
METHODS
Culture techniques. Synovial tissue from patients with rheumatoid arthritis was obtained at surgery, trimmed of fat, and cut into 3-mm3 pieces. Explants were cultured in disposable flasks (Falcon Plastics, Division of B-D Laboratories, Inc., Los Angeles, Calif.) in Dulbecco's Modified Eagle's medium in an atmosphere of 02-C02 (95: 5, v/v) as described by Evanson et al. (1, 2) . Culture medium was harvested daily for 10 days and examined for collagenase activity as well as for immunologic evidence of collagenase, a2-macroglobulin, and a1-antitrypsin. Media having collagenase activity were pooled, dialyzed against several changes of distilled water at 4°C, and lyophilized. Crude enzyme powder was stored at -20°C. Medium from the first 24 hr of culture was dialyzed and lyophilized separately from that of the remaining days.
Enzyme purification. Crude synovial collagenase powder was dissolved in 0.05 M Tris-HCl (pH 7.5) containing 0.005 M CaCl2 to a concentration of approximately 20 mg protein per ml. Ammonium sulfate fractionation was carried out at pH 7.0 and 0°C to a final saturation of 60%. The 60%o precipitate was then dissolved in 0.05 M Tris-HC1 (pH 7.5) with 0.005 M CaCl2 and dialyzed against large volumes of the same buffer.
Gel filtration was performed using reverse flow at 40C on a column 1.2 X 100 cm of Sephadex G-150 (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.), equilibrated with 0.05 M Tris-HCl (pH 7.5) containing 0.005 M CaCl2 and 0.2 M NaCl in a manner similar to that described by Harris, DiBona, and Krane (4). Fractions having collagenase activity were pooled, dialyzed against 0.05 M Tris-HCl (pH 7.5) with 0.005 M CaC12, and concentrated by pressure dialysis. The broad peak of enzyme activity obtained from Sephadex G-150 was further fractionated by gel filtration on a column (0.9 X 60 cm) of Sephadex G-75 which has been equilibrated with the same buffer in a manner similar to that used for human skin collagenase (7) . Affinity chromatography. Collagen was coupled to Sepharose 4B (Pharmacia Fine Chemicals Inc.) according to the method described for other ligands by Cuatrecasas, Wilchek, and Anfinsen (12, 13) . 25 ml of cyanogen bromide-activated Sepharose 413 was suspended in 50 ml of cold 0.2 M NaHCOa (pH 9.0), and 75 mg of purified native guinea pig skin collagen in 25 ml of 0.4 M NaCl was added immediately.
The mixture was stirred gently for 18 hr at 4VC, washed with water, and equilibrated with 0.05 M Tris-HCl (pH 7.5) containing 0.005 M CaCL2. Using these conditions, approximately 80% of the collagen was coupled to the Sepharose. 1 Affinity chromatography was performed on a column (1.2 X 1.5 cm) of collagen-Sepharose, equilibrated with 0.05 M Tris-HCl (pH 7.5) containing 0.005 M CaCl2 at 4VC. 5-10 mg of partially purified synovial collagenase was applied to the column in approximately 2 ml of the same buffer. The column was washed with starting buffer until the absorbance at 280 m, returned to base line. Collagenase was then eluted with 0.05 M Tris-HCl, 0.005 M CaCl2 containing 1.0 M NaCl. The eluent peak was dialyzed against several changes of distilled water and lyophilized. The enzyme powder was reconstituted in 0.05 M Tris-HCl (pH 7.5) containing 0.005 M CaCl2 and assayed for collagenase activity. Unbound material from the exclusion peak was handled in a similar manner and was subjected to rechromatography on collagen-Sepharose until no enzyme activity remained.
Enzyme purification was monitored using polyacrylamide gel electrophoresis on 12.5%o gels (14) . In all experiments a Tris-glycine (pH 8.5) buffer was used (15) .
Day 1 cultures. Approximately 135 mg of crude powder from day 1 cultures, which contained no detectable collagenase activity, was applied-in 0.05 M Tris-HCI, 0.005 M CaCl2, pH 7.5, to a 2.5 X 100 cm column of Sephadex G-150. Gel filtration was performed using reverse flow at 4VC in a buffer of 0.05 M Tris-HCl (pH 7.5) containing 0.005 M CaCl and 0.2 M NaCl. Eluent fractions were assayed for collagenase activity and examined for immunologic evidence of collagenase, ar2macroglobulin, and a1-antitrypsin.
Human skin collagenase. Human skin collagenase was obtained from cultures of human skin explants (16) . The electrophoretically pure fast-moving human skin collagenase was prepared as previously described (7) .
Antiserum preparations. Antiserum to synovial collagenase, purified by affinity chromatography, was prepared in rabbits, and the gamma globulin fraction was obtained in a manner similar to that previously described for preparation of anti-human skin collagenase antibodies (7) .
Anti-human ai-antitrypsin was obtained from Hoechst (Beringwerke) Pharmaceutical Co., Kansas City, Mo. and anti-human a_-macroglobulin was purchased from Hyland Laboratories, Los Angeles, Calif.
Immunologic procedures. After incubation at 370C for 1 hr and then 40C for 18 hr, precipitates were washed in 0.5 ml of cold 0.15 m NaCl. The precipitates were then dissolved in 0.5 N NaOH and their protein content determined. 0.1 ml portions of the supernatants were assayed for residual collagenase activity with "C-labeled fibrils as described below.
Preparation of tissue extracts. Approximately 10-20 g of rheumatoid synovial tissue obtained at synovectomy was trimmed of fat, minced finely with scissors, and homogenized in an all glass homogenizer at 0°C in 5.0 ml of 0.05 M Tris-HCl (pH 7.5) with 0.005 M CaC12. The homogenates were centrifuged at 10,000 g for 15 min at 4°C and the supernatants examined for enzymatic and immunologic evidence of collagenase.
Preparation of collagen substrate. Neutral salt extracted, "C-labeled collagen and acid-extracted unlabeled guinea pig skin collagen were purified according to the method of Gross (18, 19) . reconstituted guinea pig skin collagen fibrils at 370C (20 (22) . Disc electrophoresis of the products of the reaction of collagenase and collagen at 280C was performed according to the method of Nagai, Gross, and Piez (23) . Inhibition of synovial collagenase, by human whole serum and by the alpha globulins, was determined by the radioactive fibril assay after preincubation of whole serum or serum components at 370C for 30 min. Alpha globulin was obtained as commercially prepared Cohn fraction IV (Hyland Laboratories). Partially purified a2-macroglobulin and a1-antitrypsin were prepared as previously described (10) .
RESULTS
Purification and properties of synovial collagenase. Gel filtration on Sephadex G-75 of synovial collagenase, partially purified by passage through Sephadex G-150, results in the appearance of two distinct peaks of collagenase activity (Fig. 1) . Peak I emerges with the void volume, whereas peak II is retarded by the G-75. On polyacrylamide gel electrophoresis, peak I consists of a slower moving heterogeneous group of proteins (Fig. 2) while peak II consists of a homogeneous, electrophoretically fast-moving protein, referred to as (Synf) ,2 ( Fig. 2) . Although fast-moving synovial collagenase cannot be demonstrated in culture media of all patients examined, the slower moving component is always present.
The absence of fast-moving synovial collagenase from some synovial culture media prompted further purification of the slow-moving material by affinity chromatography. Fig. 3 demonstrates the appearance on a polyacrylamide gel of purified slow-moving rheumatoid synovial collagenase (Syns) eluted from collagen-Sepharose. This electrophoretically homogeneous protein was used as the immunogen in the preparation of anti-synovial collagenase (Syn.) antiserum. No caseinolytic activity is present in the purified collagenase. In this highly purified state the enzyme is relatively unstable and loses approximately 75% of its activity after storage in solution for 2 wk at -20°C.
Immunologic properties. On immunodiffusion, antiSyn. gamma globulin demonstrates a single precipitin band when reacted either with purified synovial collagenase (Syn.), the immunogen, or with crude synovial 2Abbreviations used in this paper: aHf, anti-human skin collagenase; anti-Syn., anti-slow-moving collagenase; Synf, fast-moving collagenase; Syn., slow-moving collagenase. of collagenase. A control preparation of an equal amount of nonimmune rabbit gamma globulin inhibits synovial collagenase only 3%.
Inhibition by serum components. Since human whole serum has been shown to be an effective inhibitor of synovial collagenase (2) and serum alpha globulin is a . SynS known inhibitor of both human skin and amphibian collagenases (10) , the ability of the alpha globulin components of serum to inhibit synovial collagenase was investigated. Table I (Fig. 4A) . When synovial collagenase (Syn.) and human skin collagenase are reacted in a double diffusion experiment with anti-Syns gamma globulin or antiserum to human skin collagenase (aHf), a reaction of complete identity occurs (Fig. 4B) . Similarly, fast moving (Synf) collagenase as well as the slow-moving enzyme (Syns), react with the anti-human skin collagenase (aHf) with complete immunologic identity (Fig. 4C) .
In order to determine the specificity of anti-synovial collagenase (Syn.) antiserum for the enzyme, a quantitative precipitin reaction was performed in which enzyme activity was evaluated in the supernatants. In these studies the gamma globulin fraction was used so that possible antiprotease activity of other serum fractions, such as a2-macroglobulin and ai-antitrypsin, would be avoided. Fig. 5 demonstrates the ability of monospecific anti-Syns gamma globulin to remove collagenase activity completely by precipitation. The points of minimum enzyme activity in the supernatant and maximum protein in the precipitate coincide, providing evidence that anti-Syn. antibody is specifically precipitating collagenase.
The inhibition of synovial collagenase by anti-Syn. antiserum was also confirmed by adding increasing amounts of gamma globulin to a constant amount of enzyme. After precipitation, collagenase activity in the supernatant decreases with increasing antibody concentration to a constant value of about 10% of the original activity. At this point, approximately 5 mg of anti-Syns gamma globulin produces maximum inhibition of 0.18 mg FIGURE 4 Gel diffusion analysis of antisera against rheumatoid synovial and human skin collagenases. (A) Sc, crude synovial collagenase from tissue culture; Ss, collagen-Sepharose purified slow-moving synovial collagenase; aS, antislow-moving synovial collagenase antiserum. (B) S., slowmoving synovial collagenase; aS, anti-slow-moving synovial collagenase antibody; Hsk, human skin collagenase; aHf, antiserum to fast-moving human skin collagenase. (C) S., slow-moving synovial collagenase; Sf, fast-moving synovial collagenase; aHf, antiserum to fast-moving human skin collagenase. both a2-macroglobulin and ai-antitrypsin are, indeed, effective inhibitors of crude synovial collagenase. Studies are currently in progress directed at preparing highly purified preparations of both a2-macroglobulin and ai-antitrypsin to determine the stoichiometry of inhibition of purified synovial collagenase by these antiproteases.
Studies of synovial culture medium. Examination of culture medium for collagenase activity shows a delay in the appearance of the enzyme of approximately 24-48 The protease inhibitors, a2-macroglobulin, and al-antitrypsin, can be demonstrated primarily during the first 2 days of culture, a time when enzyme activity is either very low or undetectable (Fig. 6B, C) .
When culture medium from the first 24 hr, which contains immunoreactive collagenase but little or no enzyme activity is subjected to gel filtration on Sephadex G-150, enzymatically active collagenase (Fig. 7) can be separated from the antiproteases, a2-macroglobulin, and ai-antitrypsin. Fig. 7 also shows that immunoreactive collagenase and low levels of enzyme activity are present in areas that overlap with the antiproteases, probably preventing recovery of all the enzymatic activity present in the preparation.
Synovial extracts. Although rheumatoid synovial extracts fail to demonstrate collagenase activity, the enzyme can be detected immunologically in these crude tissue extracts. Fig. 8 shows that the homogenate contains material which reacts with the monospecific antiserum to synovial collagenase (Syn.). Furthermore, the crude synovial extracts give a precipitin pattern of identity when reacted in immunodiffusion with the purified synovial collagenase (Syn.) obtained from tissue culture.
In preliminary experiments, using a synovial extract from one patient with rheumatoid arthritis, it has been possible to detect enzymatically active collagenase by gel filtration of the homogenate on Sephadex G-150 in a fashion similar to that described for extracts of human skin (9) . Recovery of active synovial collagenase appears to depend on the chromatographic separation of collagenase from the alpha globulins. When this enzymatically active fraction is reacted with collagen in solution at 280C and the reaction products are examined by disc gel electrophoresis, faster moving components can be seen when the specific viscosity has decreased by approximately 20% (Fig. 9 ). This pattern is essentially identical with that previously described for synovial collagenase from tissue culture (1) . DISCUSSION The demonstration that collagenase is present in vivo in human skin (9) strengthens the concept that col- FIGURE 8 Agar gel diffusion of a crude tissue extract of rheumatoid synovium and synovial collagenase obtained from tissue culture against anti-slow-moving synovial collagenase antiserum. Scul, synovial collagenase from culture medium; Sext, rheumatoid synovial extract; aS, anti-synovial collagenase antibody. lagenases are not only of physiologic significance in the normal processes of collagen remodeling but that they may also play a role in diseases associated with enhanced collagen degradation. In addition, a number of studies (9, 11) 34suggest that the in vitro system for collagenase production may provide an excellent experimental approach to the study of collagen remodeling.
In tissue cultures of rheumatoid synovial explants, examination of the medium reveals that collagenase is, indeed, present during the first 2 days of culture, but can only be detected immunologically at this time. On subsequent days (Fig. 6A) found in the culture medium. The serum protease inhibitors, a2-macroglobulin and al-antitrypsin, are present primarily during the first 2 days of tissue culture, suggesting that the failure to detect collagenase activity during the first 24-48 hr of culture is due to the presence of these inhibitory alpha globulins, which are presumably present in the synovial tissue at the time it is placed in serum-free culture medium. After several changes of medium, the concentration of alpha globulin is apparently lowered sufficiently to allow enzyme activity to be detected.
When enzymatically inactive medium of rheumatoid synovial explants is taken from the 1st day of culture and subjected to gel filtration on Sephadex G-150, collagenase activity can be detected. This demonstration of collagenase activity appears to be closely related to the separation of the enzyme from a2-macroglobulin and al-antitrypsin, indicating that the absence of enzymatic activity during the first 24-48 hr of tissue culture is related to the presence of these alpha globulins in the culture medium. The in vitro findings for rheumatoid synovial collagenase are similar to those reported for human skin collagenase (9) .
In the present investigation, it has also been possible to demonstrate the presence of immunoreactive collagenase in extracts of rheumatoid synovial tissue which have no detectable collagenase activity either against collagen in solution or reconstituted native collagen fibrils. This was accomplished using a monospecific antiserum prepared against rheumatoid synovial collagenase purified by affinity chromatography from tissue culture medium containing synovial explants. The precipitin reaction on immunodiffusion, between purified synovial collagenase and immunoreactive material in rheumatoid synovial extracts, demonstrates the presence in the tissue of collagenase which is immunologically identical to collagenase from tissue culture. Furthermore, preliminary observations indicate that enzymatic activity can be recovered from rheumatoid synovial extracts by gel filtration on Sephadex G-150. The presence of both at-macroglobulin and al-antitrypsin in tissue extracts of rheumatoid synovium suggests that collagenase activity in such extracts may also be masked by the inhibitory action of these alpha globulins. The role of each of these alpha globulins as inhibitors of synovial collagenase can be determined when the stoichiometry of enzyme to inhibitor is assessed with highly purified preparations of both a2-macroglobulin and ai-antitrypsin.
Recent immunologic studies have shown that species specificity exists between human and animal collagenases (7) . By utilizing antiserum to purified rheumatoid synovial collagenase, these findings have been extended to show that rheumatoid synovial and human skin collagenases share major antigenic determinants, indicating that they are immunologically identical and that organ specificity for collagenases from these tissues is un The results of the present study show that human whole serum is capable of inhibiting both the purified fastmoving (Synf) and slow-moving (Syns) synovial collagenases (Table II) . Some variability is seen in the quantitative inhibition of these synovial collagenases with the electrophoretically fast-moving collagenase being more readily inhibited than the slow-moving enzyme. Until additional information is available concerning the biochemical nature of the collagenases obtained from rheumatoid synovial tissue cultures and from rheumatoid synovial fluid, a precise comparison of these enzvmes is not possible.
The availability of a monospecific antiserum to rheumatoid synovial collagenase that reacts with identity to enzyme present in the tissue suggests that an immunologic approach may This inability to detect collagenase activity may, indeed, be related to the level of serum antiproteases in synovial fluid.
